Overview

A Study to Determine the Abuse Potential of Seltorexant Compared to Suvorexant and Zolpidem

Status:
Not yet recruiting
Trial end date:
2023-03-06
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the abuse potential of seltorexant compared to placebo and two active comparators (zolpidem and suvorexant) in non-dependent, recreational sedative users.
Phase:
Phase 1
Details
Lead Sponsor:
Janssen Research & Development, LLC
Treatments:
Suvorexant
Zolpidem